DZ Bank’s VanEck Biotech ETF BBH Stock Holding History

DZ Bank’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-325	Closed	-$62K	–	998
2021 Q4	$62K	Buy	+325	New	+$62.7K	﹤0.01%	1028

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

DZ Bank's BBH Position: Q1 2022 in Review

DZ Bank sold out of VanEck Biotech ETF (BBH) in Q1 2022, closing a stake of 325 shares — an estimated $62K sold.

DZ Bank first reported a position in BBH in Q4 2021 and held it in 1 quarter. The position peaked at $62K in Q4 2021. 115 funds tracked by Wall St. Rank hold BBH as of Q1 2022.

DZ Bank reported no remaining VanEck Biotech ETF position as of Q1 2022 after selling out during the quarter.
DZ Bank sold 325 VanEck Biotech ETF shares in Q1 2022, an estimated $62K.
DZ Bank first reported a position in VanEck Biotech ETF in Q4 2021 and held it in 1 quarter.
DZ Bank's VanEck Biotech ETF position peaked at $62K in Q4 2021.
115 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2022.

Based on DZ Bank's 13F filing for Q1 2022, filed 16 May 2022.